Generic placeholder image

Current Respiratory Medicine Reviews


ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Management of Connective Tissue Interstitial Lung Disease

Author(s): Tracy M. Frech and Mary Beth Scholand

Volume 11, Issue 2, 2015

Page: [150 - 155] Pages: 6

DOI: 10.2174/1573398X11666150619183704

Price: $65


The connective tissue diseases (CTD) are frequently associated with Interestitial lung diseases (ILD). The presence of an ILD in a patient with CTD is associated with a higher morbidity and mortality. Management of a patient with connective tissue interstitial lung disease (CTD-ILD) depends on disease severity with a focus on improving quality of life. Therapeutic interventions include medications, which aim to prevent progression to fibrosis and decrease inflammation or alveolitis, supplemental oxygen; and pulmonary rehabilitation. Comorbidities including gastroesophageal reflux disease (GERD) and obstructive sleep apnea should be addressed in all CTD-ILD patients. Appropriate referral to support groups, lung transplantation centers, and palliative care are considerations for all patients with CTDILD. The management of a patient with CTD-ILD is a multidisciplinary personalized process that is driven by the specific disease, clinical pattern, and associated comorbidities.

Keywords: Collagen vascular disease, connective tissue disease, immunosuppressive therapy, interstitial lung disease, oxygen, pulmonary rehabilitation, supportive care.

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy